| Product Code: ETC6081021 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Andorra Premenstrual Dysphoric Disorder Market Overview |
3.1 Andorra Country Macro Economic Indicators |
3.2 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume, 2021 & 2031F |
3.3 Andorra Premenstrual Dysphoric Disorder Market - Industry Life Cycle |
3.4 Andorra Premenstrual Dysphoric Disorder Market - Porter's Five Forces |
3.5 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Symptoms, 2021 & 2031F |
3.8 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.9 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Andorra Premenstrual Dysphoric Disorder Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about premenstrual dysphoric disorder (PMDD) |
4.2.2 Rising demand for advanced treatment options |
4.2.3 Growing research and development activities in the field of women's health |
4.3 Market Restraints |
4.3.1 Limited availability of approved medications for PMDD in Andorra |
4.3.2 High cost associated with specialized treatment for PMDD |
4.3.3 Stigma and lack of understanding surrounding mental health issues in Andorra |
5 Andorra Premenstrual Dysphoric Disorder Market Trends |
6 Andorra Premenstrual Dysphoric Disorder Market, By Types |
6.1 Andorra Premenstrual Dysphoric Disorder Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume, By Antidepressants, 2021- 2031F |
6.1.4 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume, By Nonsteroidal Anti-inflammatory Drugs (NSAIDs), 2021- 2031F |
6.1.5 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume, By Analgesics, 2021- 2031F |
6.1.6 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume, By Hormone Therapy, 2021- 2031F |
6.1.7 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume, By Exercise, 2021- 2031F |
6.1.8 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume, By Diet, 2021- 2031F |
6.2 Andorra Premenstrual Dysphoric Disorder Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume, By Physical Examination, 2021- 2031F |
6.2.3 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Andorra Premenstrual Dysphoric Disorder Market, By Symptoms |
6.3.1 Overview and Analysis |
6.3.2 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume, By Depression, 2021- 2031F |
6.3.3 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume, By Intense Anger, 2021- 2031F |
6.3.4 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume, By Mood Swings, 2021- 2031F |
6.3.5 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume, By Irritability, 2021- 2031F |
6.3.6 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Andorra Premenstrual Dysphoric Disorder Market, By Dosage |
6.4.1 Overview and Analysis |
6.4.2 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume, By Tablet, 2021- 2031F |
6.4.3 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume, By Injection, 2021- 2031F |
6.4.4 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Andorra Premenstrual Dysphoric Disorder Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.5.4 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Andorra Premenstrual Dysphoric Disorder Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume, By Clinic, 2021- 2031F |
6.6.3 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume, By Hospital, 2021- 2031F |
6.6.4 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Andorra Premenstrual Dysphoric Disorder Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.7.4 Andorra Premenstrual Dysphoric Disorder Market Revenues & Volume, By , 2021- 2031F |
7 Andorra Premenstrual Dysphoric Disorder Market Import-Export Trade Statistics |
7.1 Andorra Premenstrual Dysphoric Disorder Market Export to Major Countries |
7.2 Andorra Premenstrual Dysphoric Disorder Market Imports from Major Countries |
8 Andorra Premenstrual Dysphoric Disorder Market Key Performance Indicators |
8.1 Number of clinical trials focused on PMDD treatment in Andorra |
8.2 Percentage of healthcare professionals trained in diagnosing and treating PMDD |
8.3 Patient satisfaction rates with available PMDD treatment options |
9 Andorra Premenstrual Dysphoric Disorder Market - Opportunity Assessment |
9.1 Andorra Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 Andorra Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 Andorra Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Symptoms, 2021 & 2031F |
9.4 Andorra Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.5 Andorra Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 Andorra Premenstrual Dysphoric Disorder Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 Andorra Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Andorra Premenstrual Dysphoric Disorder Market - Competitive Landscape |
10.1 Andorra Premenstrual Dysphoric Disorder Market Revenue Share, By Companies, 2024 |
10.2 Andorra Premenstrual Dysphoric Disorder Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here